HIV risk reduction in the National Institute on Drug Abuse cocaine collaborative treatment study

Journal of Acquired Immune Deficiency Syndromes

Volumn 33, Issue 1, 2003, Pages 82-87

  Woody, George E ^a,b,g   Gallop, Robert ^a   Luborsky, Lester ^a   Blaine, Jack ^c   Frank, Arlene ^d,e   Salloum, Ihsan M ^f   Gastfriend, David ^e   Crits Christoph, Paul ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d Brookside Hospital   (United States)

^e HARVARD UNIVERSITY   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

^g TREATMENT RESEARCH INSTITUTE   (United States)

Author keywords

Cocaine dependence; HIV risk

Indexed keywords

COCAINE;

ADULT; ARTICLE; COCAINE DEPENDENCE; COGNITIVE THERAPY; DRUG ABUSE; ETHNOLOGY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT COUNSELING; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEXUAL BEHAVIOR; SMOKING; SUPPORT GROUP;

EID: 0038372699     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200305010-00012     Document Type: Article

References (19)

1. Wilson T, DeHovitz JA. STDs, HIV and crack cocaine: a review. AIDS Patient Care STDs 1997;11:62-66.
2. Hudgins R, McCusker J, Stoddard A. Cocaine use and risky injection and sexual behaviors. Drug Alcohol Depend 1995;37:7-14.
3. Malow RM, West JA, Corrigan SA, et al. Outcome of psychoeducation for HIV risk reduction. AIDS Educ Prev 1994;6:113-125.
4. Holmberg S. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health 1996;86:642-654.
5. Coyle SL, Needle RH, Normand J. Outreach based HIV prevention for injecting drug users: a review of published outcome data. Public Health Rep 1998;113:19-30.
6. Metzger DS, Woody GE, DePhillipis D, et al. Risk factors for needle sharing among methadone patients. Am J Psychiatr 1991;148:636-640.
7. Metzger DS, Navaline H, Woody GE. Drug abuse treatment as AIDS prevention. Public Health Rep 1998;113(suppl 1):97-106.
8. Metzger DS, Woody GE, McLellan AT, et al. Human immunodeficiency virus seroconversion among in- and out-of-treatment intravenous drug users: an 18-month, prospective follow-up. J Acquir Immune Defic Syndr Hum Retrovirol 1993;6:1149-1156.
9. Avins AL, Lindan CP, Woods WJ, et al. Changes in HIV-related behaviors among heterosexual alcoholics following addiction treatment. Drug Alcohol Depend 1994;36:109-113.
10. Shoptaw S, Frosch DL, Rawson RA, et al. Cocaine abuse counseling as HIV prevention. AIDS Educ Prev 1997;9:509-518.
11. Remien RH, Goetz R, Rabkin JG, et al. Remission of substance use disorders: gay men in the first decade of AIDS. J Stud Alcohol 1995;56:226-232.
12. Crits-Christoph P, Siqueland L, Blaine JD, et al. The National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Arch Gen Psychiatry 1997;54:721-726.
13. Crits-Christoph P, Siqueland L, Blaine JD, et al. Psychosocial treatments for cocaine dependence: results of the NIDA Cocaine Collaborative Study. Arch Gen Psychiatry 1999;56:493-502.
14. Navaline HA, Snider EC, Petro C, et al. An automated version of the Risk Assessment Battery (RAB): enhancing the assessment of risk behaviors. AIDS Res Hum Retroviruses 1994;10(suppl 2):S281-S283.
15. Metzger DS, Nalvaline HA, Woody GE. Assessment of substance abuse: HIV Risk Assessment Battery. In Carson-Dewitt, ed. Encyclopedia of Drugs, Alcohol and Addictive Behavior Farmington Hills, MI: Macmillan Reference USA, 2001.
16. First M, Spitzer RL, Gibbon M, et al. Structured Interview for Axis I and II for DSM-IV. New York: New York Psychiatric Center, 1994.
17. Brooner RK, Bigelow GE, Strain EC, et al. Intravenous drug abusers with antisocial personality disorder: increased HIV risk behavior. Drug Alcohol Depend 1990;26:39-44.
18. Brooner RK, Greenfield L, Schmidt CW, et al. Antisocial personality disorder and HIV infection among intravenous drug abusers. Am J Psychiatry 1993;150:53-58.
19. McLellan AT, O'Brien CP, Lewis DL, et al. Drug addiction as a chronic medical illness: implications for treatment, insurance and evaluation. JAMA 2000;284:1689-1695.